As the US FDA weighs implementation of a suffix-based naming system for biologics, the World Health Organization has decided to shelve, at least for now, its own plan for a different naming convention.
Nine months after issuing a final guidance on nonproprietary naming of biological products, FDA has yet to approve a 351(a)...






